New! Sign up for our free email newsletter.
Science News
from research organizations

Combining genetics and brain MRI can aid in predicting chances of Alzheimer's disease

Date:
June 29, 2022
Source:
Simon Fraser University
Summary:
Researchers are studying how a combination of genetics and brain MRIs may be used to predict the chances of developing Alzheimer's disease in the future.
Share:
FULL STORY

Simon Fraser University researchers are studying how a combination of genetics and brain MRIs may be used to predict the chances of developing Alzheimer's disease in the future.

In a newly published study, researchers from SFU's Functional and Anatomical Imaging & Shape Analysis Lab (FAISAL) identified distinct properties of brain MRIs and genetics that impact the prediction of Dementia of Alzheimer's Type, or DAT, for patients at various stages of the disease, then developed a biomarker that can help predict future conversion to DAT.

"Our findings reveal that while genetic features have lower predictive power than MRI features, combining both modalities can improve the performance in predicting the future conversion to DAT," says study lead author Ghazal Mirabnahrazam, a research assistant currently completing a master's degree in engineering science at SFU.

Dementia scores based on genetic data were shown to better predict future DAT progression in currently normal patients who will develop DAT at a later time, while MRI data, which reflects anatomical changes in the brain, was shown to better predict future DAT in those with mild cognitive impairment.

"In a clinical setting, clinicians can use our model to predict a quantitative score indicating the similarity between a subject's observed patterns based on MRI and genetic data at the time of clinical visit and DAT patterns," says senior author Mirza Faisal Beg, a professor in SFU's School of Engineering Science.

"This is extremely useful, specifically at the MCI (mild cognitively impaired) stage in identifying those who will progress to DAT in the future. Being able to accurately estimate the chance of future conversion to DAT using only baseline information is extremely valuable because it provides practitioners with deep insight and enough time to plan appropriate care for each patient based on their probability of developing Alzheimer's disease.

"Furthermore, it can provide potentially critical information for drug trials and the development of preventative measures," adds Beg. "This information can aid in the selection of the appropriate cohort of patients for clinical trials, which can lead to a more promising outcome."


Story Source:

Materials provided by Simon Fraser University. Note: Content may be edited for style and length.


Journal Reference:

  1. Ghazal Mirabnahrazam, Da Ma, Sieun Lee, Karteek Popuri, Hyunwoo Lee, Jiguo Cao, Lei Wang, James E. Galvin, Mirza Faisal Beg. Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer’s Disease. Journal of Alzheimer's Disease, 2022; 87 (3): 1345 DOI: 10.3233/JAD-220021

Cite This Page:

Simon Fraser University. "Combining genetics and brain MRI can aid in predicting chances of Alzheimer's disease." ScienceDaily. ScienceDaily, 29 June 2022. <www.sciencedaily.com/releases/2022/06/220629084057.htm>.
Simon Fraser University. (2022, June 29). Combining genetics and brain MRI can aid in predicting chances of Alzheimer's disease. ScienceDaily. Retrieved March 18, 2024 from www.sciencedaily.com/releases/2022/06/220629084057.htm
Simon Fraser University. "Combining genetics and brain MRI can aid in predicting chances of Alzheimer's disease." ScienceDaily. www.sciencedaily.com/releases/2022/06/220629084057.htm (accessed March 18, 2024).

Explore More

from ScienceDaily

RELATED STORIES